IRD 1.82 ▲ 5.81% Live Trading Data - Stocknear

Opus Genetics Inc.

NASDAQ: IRD · Real-Time Price · USD
1.82
0.10 (5.81%)
At close: Sep 26, 2025, 3:59 PM
1.83
0.55%
After-hours: Sep 26, 2025, 07:55 PM EDT
5.81%
Bid 1.77
Market Cap 109.03M
Revenue (ttm) 15.42M
Net Income (ttm) -58.27M
EPS (ttm) -1.88
PE Ratio (ttm) -0.97
Forward PE -4.05
Analyst Buy
Dividends n/a
Ask 1.83
Volume 540,834
Avg. Volume (20D) 263,269
Open 1.75
Previous Close 1.72
Day's Range 1.69 - 1.83
52-Week Range 0.65 - 1.83
Beta 0.30
Ex-Dividend Date n/a

About IRD

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IRD
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for IRD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Opus Genetics Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+9.6%
Opus Genetics shares are trading higher after the ... Unlock content with Pro Subscription
9 months ago
+18.93%
Opus Genetics shares are trading higher after the company announced it secured an FDA agreement under special protocol assessment for its Phase 3 trial of Oral APX3330 in diabetic retinopathy.